Our analyses of comprehensive BRCA data suggested that KDM7A-DT genetic alterations and expression aberrations in primary BRCA play essential roles in multiple pathways referring to TP53 missense mutation, CNA, tumor genome instability, uncontrolled proliferation, pathways driving cancer invasiveness, and clinical outcomes. This evidence concerns the gene KDM7A and neoplasm.